Ball, Allison <br/><br/>
Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1.  [electronic resource] 

 -  American journal of physiology. Endocrinology and metabolism  Nov 2006 
 - E922-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0193-1849 
<br/><br/><label>Standard No.: </label>10.1152/ajpendo.00602.2005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Proteins--pharmacology<br/>Carcinogens--pharmacology<br/>Cell Line, Transformed<br/>Female<br/>Humans<br/>Myometrium--cytology<br/>Parturition--physiology<br/>Pregnancy<br/>Pregnancy Trimester, Third--physiology<br/>Protein Kinase C--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-fos--genetics<br/>Proto-Oncogene Proteins c-jun--genetics<br/>RNA, Messenger--metabolism<br/>Receptors, G-Protein-Coupled--metabolism<br/>Receptors, Oxytocin--genetics<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Transcription Factor AP-1--genetics